In conclusion, in this comprehensive analysis of real-world practice regarding EGFR mutation testing in East Asia, we found that 39.5% of advanced NSCLC patients attending our center were tested for EGFR mutations from January 2007 to July 2010. Here, EGFR is linked to non-small cell lung carcinoma.